To assess BIRC3 protein expression in tumor cell niche versus vascular niche, we performed immunohistochemistry (IHC) analyses of a TMA comprised of patient-derived GBM biopsy samples as well as normal brain controls. The gene discussed is BIRC3; the disease is glioblastoma.